Should a scientific epilepsy journal feature a picture highlighting the war in Ukraine on its front cover?

It is part of the human condition that adversities which affect people close to us have stronger emotional effects – and release greater energies – than traumas happening to those we are less immediately connected with. This means that it is justifiable that a scientific publication which calls itself the “European Journal of Epilepsy” should respond to a war in a European country, especially when this war does not only pose an immediate threat to the lives of people with ...

Seguir leyendo →
0

ABCG2, SCN1A and CYP3A5 genes polymorphism and drug-resistant epilepsy in children: A case-control study

Epilepsy is a common neurological disorder in children with an incidence rate between 41 and 187 per 100,000 persons globally (1, 2). Developing countries, particularly in rural areas have higher incidence rates (2). Although several antiseizure medicines (ASM) have been developed in recent decades, it is estimated that about 20% of patients fail to respond to standard therapies and continue to experience debilitating drug-resistant seizures (1, 3).

Seguir leyendo →
0

Clinical Characteristics and Treatment Experience of Individuals with SCN8A Developmental and Epileptic Encephalopathy (SCN8A-DEE): Findings from an Online Caregiver Survey

SCN8A developmental and epileptic encephalopathy (SCN8A-DEE) is a rare and serious genetic epilepsy syndrome characterized by early-onset developmental delay and/or regression, cognitive impairment, and multiple intractable seizure types.[1-4] The SCN8A gene is highly expressed in the central nervous system and encodes the Nav1.6 voltage-gated sodium ion channel, which has a major role in regulating the excitatory neuronal networks in the brain.[1-3]

Seguir leyendo →
0

Brivaracetam as add-on treatment in patients with post-stroke epilepsy: real-world data from the BRIVAracetam add-on First Italian netwoRk Study (BRIVAFIRST)

Stroke is a leading disease worldwide, with an estimated incidence of more than 15 million cases annually [1]. Post-stroke epilepsy (PSE), which is defined as the occurrence of one or more unprovoked epileptic seizures at least one week after the stroke, develops in at least 4-6% of the stroke population [2]. Cerebrovascular disease is one of the most common causes of acquired epilepsy and accounts for about 10-15% of all newly diagnosed epilepsy cases [2]. Although PSE has overall a ...

Seguir leyendo →
0

Reflex seizures in rare monogenic epilepsies

Reflex seizures (RSs) are epileptic events consistently induced by specific triggers. They occur in epilepsies of varied etiologies and are often accompanied by spontaneous seizures. The genetic background of RSs is heterogeneous and polygenic or multifactorial inheritance is suspected in the majority of cases. Although causative single-gene variants are rarely identified, the number of genes associated with RSs is gradually increasing. In this article, we describe individuals presenting reflex seizures as predominant epileptic events in whom we identified pathogenic and ...

Seguir leyendo →
0

New-onset seizure at high altitude among healthy males

In high-altitude areas (HAA), oxygen in inspired air is at a lower partial pressure. The ensuing hypoxia elicits neurohumoral and hemodynamic responses in both brain and lungs with varying severity of cerebral and pulmonary syndromes [1,2]. While there is data on the risk of developing certain pathophysiological conditions at high altitude, such as cerebral or pulmonary edema, there is a paucity of literature detailing the incidence of seizures after ascent to HAA [3].

Seguir leyendo →
0

De novo myoclonic status epilepticus in Alzheimer disease

The association between Alzheimer’s disease (AD) and epileptic seizures is well known [1, 2]. Several studies reported an increased risk of late-onset unprovoked seizures in AD patients. The most common seizure type is represented by non-motor focal seizures with impaired awareness [1]; myoclonic jerks can also occur [1, 3]. Non-convulsive status epilepticus has been rarely reported.

Seguir leyendo →
0

A complex epileptic and dysmorphic phenotype associated with a novel frameshift KDM5B variant and deletion of SCN gene cluster

The histone demethylase family plays a key role in chromatin structure and gene regulation during development. Mutations in the genes encoding the lysine demethylase 5 (KDM5) were reported in individuals with many diseases, including neurodevelopmental disorders such as intellectual disability. Recently, KDM5B has been identified as a gene regulator causative of recessive neurodevelopmental disorders. Although numerous variants in this gene have been identified, genotype / phenotype correlation remains variable.

Seguir leyendo →
0

Surgery for Tuberous Sclerosis Complex-related epilepsy: Risk factors for an unfavorable seizure outcome.

Tuberous sclerosis complex (TSC) is a multiorgan autosomal dominant disorder associated with mutations in either the TSC1 (encoding hamartin) or TSC2 (encoding tuberin) genes. [1,2,3] Epilepsy is a hallmark of TSC, with two-third of patients developing drug resistance. [4] There is general agreement that epileptic seizures originate in brain cortical tubers or in the surrounding cortex, [5] which are present in 90% of patients regardless of age. [6] Other typical brain abnormalities of the central nervous system (CNS) involvement in ...

Seguir leyendo →
0

Perampanel in real-world clinical care of adolescent and adult patients with epilepsy: Results from the retrospective Phase IV PROVE Study

Perampanel, a selective, non-competitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist, is a once-daily oral anti-seizure medication (ASM) for focal-onset seizures (FOS, previously referred to as partial-onset seizures) and generalized tonic-clonic (GTC) seizures (previously primary generalized tonic-clonic seizures) [1, 2]. In the US, perampanel is approved as an adjunctive treatment and monotherapy for FOS in patients aged ≥4 years, and as an adjunctive treatment for GTC seizures in patients aged ≥12 years [1].

Seguir leyendo →
0
Página 41 de 179 «...1020303940414243...»